X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.340
-0.028 (-7.50%)
At close: Nov 20, 2024, 4:00 PM
0.339
-0.002 (-0.44%)
Pre-market: Nov 21, 2024, 4:14 AM EST
X4 Pharmaceuticals Stock Forecast
XFOR's stock price has decreased by -57.25% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for X4 Pharmaceuticals stock have an average target of 2.88, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 746.06% from the current stock price of 0.34.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for XFOR stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $1.5 | Strong Buy | Maintains | $5 → $1.5 | +340.66% | Nov 14, 2024 |
| Stifel | Stifel | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +1,075.09% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,368.86% | Jun 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +1,368.86% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $5 | Strong Buy | Maintains | $3 → $5 | +1,368.86% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
6.45M
Revenue Next Year
44.93M
from 6.45M
Increased by 596.79%
EPS This Year
-0.22
from -0.57
EPS Next Year
-0.48
from -0.22
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 14.4M | 147.7M | 250.7M | ||
| Avg | 6.4M | 44.9M | 103.5M | ||
| Low | 3.0M | 9.1M | 22.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 2,191.3% | 458.1% | ||
| Avg | - | 596.8% | 130.3% | ||
| Low | - | 41.7% | -51.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.08 | -0.09 | 0.20 | ||
| Avg | -0.22 | -0.48 | -0.26 | ||
| Low | -0.67 | -0.69 | -0.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.